[HTML][HTML] Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease
J Dittrich, F Beutner, A Teren, J Thiery, R Burkhardt… - Atherosclerosis, 2019 - Elsevier
Background and aims Dyslipidemia is a major risk factor for atherosclerotic cardiovascular
disease (ASCVD). As key regulators of lipoprotein metabolism, apolipoproteins (apos) are
discussed as vascular risk factors. This study aimed to analyze associations of major plasma
apos with coronary artery disease (CAD), peripheral artery disease (PAD) and carotid artery
plaque (CAP) to elucidate their diagnostic potential in risk assessment. Methods ApoA-I,
apoA-II, apoA-IV, apoB-100, apoC-I, apoC-III, apoE, and apoJ were simultaneously …
disease (ASCVD). As key regulators of lipoprotein metabolism, apolipoproteins (apos) are
discussed as vascular risk factors. This study aimed to analyze associations of major plasma
apos with coronary artery disease (CAD), peripheral artery disease (PAD) and carotid artery
plaque (CAP) to elucidate their diagnostic potential in risk assessment. Methods ApoA-I,
apoA-II, apoA-IV, apoB-100, apoC-I, apoC-III, apoE, and apoJ were simultaneously …
